[Translation] A multicenter, randomized, double-blind, placebo-controlled phase III clinical study of compound Ganoderma lucidum spore capsules in reducing fatigue, insomnia, and anorexia caused by chemotherapy in patients with non-small cell lung cancer
在Ⅱ期临床试验的基础上,评价复方灵芝孢子胶囊对减少非小细胞肺癌患者疲乏-失眠-食欲减退症状群(化疗毒副反应)的作用。同时评价复方灵芝孢子胶囊辅助化疗对患者其他化疗毒副反应、患者KPS评分、患者FACT-L生活质量评分、免疫功能、化疗完成情况、舌脉象情况、MDASI-TCM症状及程度评分、体重、实体瘤疗效等方面的影响。
[Translation] Based on the Phase II clinical trial, the effect of Compound Ganoderma Lucidum Spore Capsules on reducing the fatigue-insomnia-anorexia symptom group (chemotherapy toxicity) in patients with non-small cell lung cancer was evaluated. At the same time, the effect of Compound Ganoderma Lucidum Spore Capsules adjuvant chemotherapy on other chemotherapy toxicity, KPS score, FACT-L quality of life score, immune function, chemotherapy completion, tongue and pulse condition, MDASI-TCM symptom and degree score, body weight, and solid tumor efficacy was evaluated.